Revelation Biosciences, Inc.
REVB· Nasdaq
Released Jun 22, 2021, after the close
10-Q filed Jun 22, 2021, 83 days after period end · 0001213900-21-033574
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2021 | Q1 2020 |
|---|---|---|
| Net Income | -$2.61M | -$7.16K |
| EPS Diluted | -$0.42 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Revelation Biosciences, Inc. · CIK 1810560 · Engraved from SEC EDGAR
ended Mar 31, 2021 · filed Jun 22, 2021 · 83 d after period end